OpenAlex
PricingAboutJobs
Log inGet started
Work

A reassessment of risks and benefits of dopamine agonists in Parkinson's disease

HTML

Year: 2009
Type: review
Source: The Lancet Neurology
DOI: 10.1016/s1474-4422(09)70225-x
Authors: Angelo Antonini, Eduardo Tolosa, Yoshikuni Mizuno, Mitsutoshi Yamamoto, Werner H Poewe
Institutions: Istituti Clinici di Perfezionamento, Biomedical Research Networking Center on Neurodegenerative Diseases, Hospital Clínic de Barcelona, Universitat de Barcelona, Juntendo University, Kagawa Prefectural Central Hospital, Innsbruck Medical University, Universität Innsbruck
Language: English

Topic: Parkinson's Disease Mechanisms and Treatments
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Keywords: dopamine agonists, Parkinson's disease, risk-benefit assessment, levodopa, motor complications, disease progression, adverse events, impulse control disorders, lower limb edema, daytime somnolence, fibrosis, treatment decision-making
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2169802060
FWCI: 2.616
Cites: 106
Cited by: 217
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms